Literature DB >> 16021058

Pelvic organ descent and symptoms of pelvic floor disorders.

Chiara Ghetti1, W Thomas Gregory, S Renee Edwards, Lesley N Otto, Amanda L Clark.   

Abstract

OBJECTIVE: This study evaluates the relationship between symptoms of pelvic floor disorders, and measurement of pelvic organ prolapse. STUDY
DESIGN: This retrospective cross-sectional study assessed prolapse in 905 women in an academic urogynecologic practice using the Pelvic Organ Prolapse Quantification exam. Symptoms were assessed with a Likert symptom questionnaire and the Urogenital Distress Inventory. Relationships between symptoms and prolapse were analyzed using Spearman's correlation.
RESULTS: Symptoms of "bulging" correlated moderately to the greatest extent of prolapse (r=0.4, P<.001). Frequency of bother progressively increases when the leading edge descends from -3 and 0. Between +1 and +5, 90% of women report bother. Symptoms typically attributed to anterior or posterior wall prolapse did not correlate with descent of the respective compartment.
CONCLUSION: "Bulging" is the principle symptom that correlates with prolapse severity. We found no discrete anatomic position that discriminates between prolapse as a disease state and normal anatomic variation.

Entities:  

Mesh:

Year:  2005        PMID: 16021058     DOI: 10.1016/j.ajog.2004.12.004

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  42 in total

1.  Validation, reliability, and responsiveness of Prolapse Quality of Life Questionnaire (P-QOL) in a Brazilian population.

Authors:  Andrea Scarlato; Carolina Chaves Cunha Souza; Eliana Suelotto Machado Fonseca; Marair Gracio Ferreira Sartori; Manoel João Batista de Castello Girão; Rodrigo Aquino Castro
Journal:  Int Urogynecol J       Date:  2011-01-28       Impact factor: 2.894

2.  Depressive symptoms in women seeking surgery for pelvic organ prolapse.

Authors:  Chiara Ghetti; Jerry L Lowder; Rennique Ellison; M A Krohn; Pamela Moalli
Journal:  Int Urogynecol J       Date:  2010-03-24       Impact factor: 2.894

3.  Correlation between anatomical findings and symptoms in women with pelvic organ prolapse using an artificial neural network analysis.

Authors:  Stefano Salvatore; Maurizio Serati; Gabriele Siesto; Elena Cattoni; Mara Zanirato; Marco Torella
Journal:  Int Urogynecol J       Date:  2010-10-23       Impact factor: 2.894

4.  Symptomatic pelvic organ prolapse at midlife, quality of life, and risk factors.

Authors:  Xavier Fritel; Noëlle Varnoux; Marie Zins; Gérard Breart; Virginie Ringa
Journal:  Obstet Gynecol       Date:  2009-03       Impact factor: 7.661

Review 5.  Repair of pelvic organ prolapse: what is the goal?

Authors:  Margarita M Aponte; Nirit Rosenblum
Journal:  Curr Urol Rep       Date:  2014-02       Impact factor: 3.092

6.  Lower urinary tract symptoms in women with pelvic organ prolapse.

Authors:  Jerry L Lowder; Elizabeth A Frankman; Chiara Ghetti; Lara J Burrows; Marijane A Krohn; Pamela Moalli; Halina Zyczynski
Journal:  Int Urogynecol J       Date:  2010-01-14       Impact factor: 2.894

7.  Pelvic Floor Symptoms and Spinal Curvature in Women.

Authors:  Isuzu Meyer; Tatum A McArthur; Ying Tang; Jessica L McKinney; Sarah L Morgan; Holly E Richter
Journal:  Female Pelvic Med Reconstr Surg       Date:  2016 Jul-Aug       Impact factor: 2.091

8.  Correlation of pelvic organ prolapse staging with lower urinary tract symptoms, sexual dysfunction, and quality of life.

Authors:  Serife Esra Cetinkaya; Fulya Dokmeci; Omer Dai
Journal:  Int Urogynecol J       Date:  2013-03-28       Impact factor: 2.894

Review 9.  Pelvic floor disorders following vaginal or cesarean delivery.

Authors:  Hafsa Memon; Victoria L Handa
Journal:  Curr Opin Obstet Gynecol       Date:  2012-10       Impact factor: 1.927

10.  Is there a pelvic organ prolapse threshold that predicts pelvic floor symptoms?

Authors:  Robert E Gutman; Daniel E Ford; Lieschen H Quiroz; Stuart H Shippey; Victoria L Handa
Journal:  Am J Obstet Gynecol       Date:  2008-10-01       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.